An international regulatory clinical trial comparative

Beth Ann Fiedler, Robert J. Bebber
  • International Journal of Pharmaceutical and Healthcare Marketing, June 2013, Emerald
  • DOI: 10.1108/ijphm-04-2013-0014

What is it about?

This paper compares leading countries and their methods in the conduct of clinical trials in order to point out important aspects of each to improve the overall process.

Why is it important?

Clinical trials form the basis of new medicine and devices and utilizing the best practices can help formulate better patient outcomes that reduce patient risk.

Read Publication

http://dx.doi.org/10.1108/ijphm-04-2013-0014

The following have contributed to this page: Beth A. Fiedler